期刊文献+

糖原合成酶基因M416V多态性与2型糖尿病的相关性 被引量:1

The association of glycogen synthase gene polymorphism (M416V) with type 2 diabetes in the Chinese population
下载PDF
导出
摘要 目的 探讨糖原合成酶 ,即GlycogenSynthase(GS)基因M4 16V多态性与 2型糖尿病(T2DM)的相关性。 方法 利用聚合酶链式反应限制性片段长度多态性 (PCR RFLP)技术分析2 5 2例T2DM患者、196例非DM对照者GS基因第 10外显子第 4 16号位点上由蛋氨酸 (Methionine)置换成缬氨酸 (Valine)的变异 ,即M4 16V。 结果  (1)T2DM组的GS基因M4 16V的Val等位基因频率为 10 .3% ,对照组的Val等位基因频率为 6 .4 % ;T2DM组中的Val等位基因频率显著高于对照组 ,P =0 .0 37。 (2 )在T2DM组中 ,具有GS基因Val等位基因者的BMI值明显高于无Val等位基因者 (P =0 .0 2 4 ) ,具有GS基因Val等位基因者的 2hPG值明显高于无Val等位基因者 (P =0 .0 0 5 )。 结论 GS基因 4 16位点上的Val等位基因与T2DM的发病有一定的相关性 ,并且它可能参与胰岛素抵抗 (肥胖、高血压、高血脂等 ) Objective To investigate the association of the M416V(Methionine to Valine at position 416 in the exon 10) polymorphism of muscle glycogen synthase (GS) gene with type 2 diabetes mellitus (DM) in the Chinese population. Methods Genotypes were determined by PCR RFLP in 252 type 2 DM patients and 196 non diabetic controls. Results (1) The frequency of allele Val(Valine) of M416V was 10.3% in type 2 DM patients and 6.4% in the control subjects. It was significantly higher than the control subjects ( P =0.037). (2) The BMI(Body mass index) of type 2 DM patients with allele Val was significantly higher than those of type 2 DM patients without allele Val ( P =0.024). The 2 hPG (Plasma glucose) of type 2 DM patients with allele Val was also significantly higher than those of type 2 DM patients without allele Val ( P =0.005). Conclusion The Val allele of GS gene M416V polymorphism may be associated with type 2 DM onset in the Chinese, and it also could be involved in its development in the insulin resistant (obest, hypertension and hyperlipemia, etc).
出处 《中国糖尿病杂志》 CAS CSCD 2003年第5期353-356,共4页 Chinese Journal of Diabetes
基金 教育部留学回国人员科研启动基金
关键词 糖原合成酶 基因多态性 2型糖尿病 相关性 胰岛素抵抗 Glucogen synthase gene polymorphism Type2 DM Insulin resistant
  • 相关文献

参考文献11

  • 1[1]Kida Y, Del Puente AE, Bogardus C. Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle.J Clin Invest,1990, 85:476-481.
  • 2[2]Camilla SJ, Matti H, leif C. Groop:Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes,1992,41:598-604.
  • 3[3]Shulman GI, Rothman DL, Jue T, et al. Quantiation of muscle glycogen synthesis in normal subjects and subjects with non-insulin dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Englj Med,1990,322:223-228.
  • 4[4]Shimomura H, Sanke T, Ueda K, et al. A missense mutation of the muscle glycogen synthase gene (M416V) is associated with insulin resistance in the Japanese population . Diabetologia,1997,40:947-952.
  • 5[5]Kuroyama H, Sanke T, Ohagi S, et al. Simple tandem repeat DNA polymorphism in the human glycogen synthasa gene is associatd with NIDDM in Japanese subjects Diabetologia, 1994,37:536-539.
  • 6[6]Orho M, Ijas PN, Jantti CS, et al. Isolation and characterization of the human muscle glycogen synthase gene. Diabetes, 1995,44: 1099-1105.
  • 7[7]De Fronzo RA. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes,1988,37:667-687.
  • 8[8]Vaag A, Henriksen JE, Nielsen HB. Decreased insulin activation of glycogen synthase in skeletal muscle in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest,1992,89:782-788.
  • 9[10]Groop LC, Kankuri M, Jantti CS, et al. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med,1993,328:10-15.
  • 10[11]Thorburn AW, Gumbiner B, Bulacan F, et al. Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin-dependent diabetes mellitus.J Clin Invest,1991,87:489-495.

同被引文献2

  • 1A. E. Civitarese,C. P. Jenkinson,D. Richardson,M. Bajaj,K. Cusi,S. Kashyap,R. Berria,R. Belfort,R. A. DeFronzo,L. J. Mandarino,E. Ravussin. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes[J] 2004,Diabetologia(5):816~820
  • 2Y. M. Cho,B.-S. Youn,S. S. Chung,K. W. Kim,H. K. Lee,K.-Y. Yu,H. J. Park,H. D. Shin,K. S. Park MD PhD. Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans[J] 2004,Diabetologia(3):559~565

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部